There are several reasons why our researchers chose the eventual route of administration as transdermal absorption - skin patches.

Transdermal absorption was chosen to avoid the first pass effect (reduced absorption due to oral consumption). Our product delivers medication from our patch directly into the body through the opening of pores initiated by the world's first far-infrared skin patch technology.

When pasted on the recommended acupoints, our patch focuses on healing from that area, with a synergistic effect.

KPLASS skin patches do not require any oral consumption, hence eliminating the first pass effect. The first pass effect (also known as first-pass metabolism or pre-systemic metabolism) is a phenomenon of drug metabolism whereby the concentration of a drug, specifically when administered orally, is greatly reduced before it reaches the systemic circulation. Simply put, we ensure that our active ingredients reach the intended sites at their full strength.

Oral medications might come with drowsiness as side effects and hinder you from doing the things you love. Certain individuals might even be allergic to the drug components.

Hence, our product is non-invasive, maximises efficiency and the benefits of the product, while sidestepping drug allergies and drowsiness. This ensures that you enjoy living in the moment. Every single moment.